12:00 AM
Jan 21, 2013
 |  BC Week In Review  |  Company News  |  Deals

Cangenix Ltd., Galapagos deal

Galapagos acquired structure-based drug discovery company Cangenix for £1 million ($1.6 million) up front in cash and up to £440,000 ($709,632) in milestones. Cangenix...

Read the full 99 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >